MUC1 and breast cancer: Cell permeability inhibitors such as protein transduction domain MUC1 inhibitory peptide (PMIP), which interfere with MUC1-EGFR interactions, have been extensively developed and shown to effectively kill breast cancer cells both in vitro and in tumor models [73].